<Disease><Name>GLYCOGEN STORAGE DISEASE TYPE IIB. DANON DISEASE</Name><Synonym>LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY; PSEUDOGLYCOGENOSIS II</Synonym><OMIM><Number>300257</Number><URL>http://omim.org/entry/300257</URL></OMIM><Orphanet><Number>34587</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=34587</URL></Orphanet><Protein><Number>Lysosome-associated membrane glycoprotein 2</Number><URL>http://www.uniprot.org/uniprot/P13473</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>Xq24</Gene><ICD>E74.0</ICD><Summary>rare ;X-linked dominant;lysosome-associated protein-2 (LAMP-2) mutations</Summary><Symptoms><symtomp><id>2459</id><symptom>cardiac arrhythmia, dysrhythmia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1877</id><symptom>cardiomegaly</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3676</id><symptom>cardiomyopathy, dilated</symptom><category>CARDIOVASCULAR SYSTEM | CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1883</id><symptom>ECG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1837</id><symptom>exercise intolerance</symptom><category>MUSCLES</category></symtomp><symtomp><id>1878</id><symptom>heart failure, cardiac failure</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2356</id><symptom>hydrops fetalis</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2468</id><symptom>impaired visual acuity</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2147</id><symptom>muscle cramps</symptom><category>MUSCLES</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>2325</id><symptom>myopia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2554</id><symptom>onset, fetus / fetal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1704</id><symptom>sudden death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2201</id><symptom>tachykardia / tachycardia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1840</id><symptom>tachykardia, paroxysmal / tachycardia, paroxysmal</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1869</id><symptom>tachypnea, hyperpnea, dyspnea, hyperventilation</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>694</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>400.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>309</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>150.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>308</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>60.00</min><max>400.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>947</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>25.00</min><max>90.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>normal/inc</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7942</id><title>Danon Disease</title><author>Taylor MRG,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Adler ED</co_aut></literature><literature><id>5190</id><title>Prenatal Hypertrophic Cardiomyopathy due to Danon Disease</title><author>Kuster A,</author><journal>Journal of Inborn Errors of Metabolism and Screening, 13th International Congress of Inborn Errors of Metabolism, Rio de Janeiro, Brazil</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4020</id><title>A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: </title><author>Bottillo I,</author><journal>Cardiovasc Pathol</journal><year>2016</year><book /><volume>25</volume><number>5</number><pages>423-431</pages><co_aut>et al.</co_aut></literature><literature><id>4021</id><title>Danon disease - dysregulation of autophagy in a multisystem disorder with cardiomyopathy</title><author>Rowland TJ,</author><journal>J Cell Sci</journal><year>2016</year><book /><volume>129</volume><number>11</number><pages>2135-2143</pages><co_aut>et al.</co_aut></literature><literature><id>3617</id><title>Danon disease: a phenotypic expression of LAMP-2 deficiency</title><author>Endo Y,</author><journal>Acta Neuropathol</journal><year>2015</year><book /><volume>129</volume><number>3</number><pages>391-398</pages><co_aut>Furuta A, Nishino I</co_aut></literature><literature><id>3620</id><title>LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease.</title><author>Rothaug M,</author><journal>Acta Neuropathol Commun</journal><year>2015</year><book /><volume>3</volume><number>0</number><pages>6</pages><co_aut>et al.</co_aut></literature><literature><id>3618</id><title>Danon disease: clinical features, evaluation, and management</title><author>Dsouza RS,</author><journal>Circ Heart Fail</journal><year>2014</year><book /><volume>7</volume><number>5</number><pages>843-849</pages><co_aut>et al.</co_aut></literature><literature><id>3619</id><title>Unclassified cardiomyopathies in neuromuscular disorders</title><author>Finsterer J,</author><journal>Wien Med Wochenschr</journal><year>2013</year><book /><volume>163</volume><number>21</number><pages>505-513</pages><co_aut>Stoellberger C</co_aut></literature><literature><id>3621</id><title>Morphologic and clinical aspects of Danon disease in a patient with a mutation c.137G </title><author>Fidzianska A,</author><journal>Neuropediatrics</journal><year>2013</year><book /><volume>44</volume><number>5</number><pages>276-280</pages><co_aut>et al.</co_aut></literature><literature><id>1105</id><title>Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)</title><author>Nishino I</author><journal>Nature</journal><year>2000</year><book /><volume>406</volume><number>0</number><pages>906-910</pages><co_aut>et al.</co_aut></literature><literature><id>144</id><title>Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency</title><author>Hirschhorn R</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2443-2464</pages><co_aut /></literature></Literatures></Disease>